Levothyroxine Sodium

Product NDC
50436-5503
11-digit product format
504365503
Labeler code
50436
Product ID
50436-5503_27293535-56c6-42dd-baa4-08e8e8ead721
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Levothyroxine Sodium
Dosage form
TABLET
Route
ORAL
Labeler
Unit Dose Services
Application
NDA021210
Marketing category
NDA
Marketing start
2003-12-01
Marketing end
0000-00-00
Substance
LEVOTHYROXINE SODIUM ANHYDROUS
Active strength
0 mg/1
Pharmacologic classes
l-Thyroxine [EPC],Thyroxine [CS]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct50436-5503IInactivated by FDA2026-07-31
excluded packagepackage50436-550350436-5503-1IInactivated by FDA2026-07-31
excluded packagepackage50436-550350436-5503-2IInactivated by FDA2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 12 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021210-001UNITHROIDLEVOTHYROXINE SODIUM0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-002UNITHROIDLEVOTHYROXINE SODIUM0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-003UNITHROIDLEVOTHYROXINE SODIUM0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-004UNITHROIDLEVOTHYROXINE SODIUM0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-005UNITHROIDLEVOTHYROXINE SODIUM0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-006UNITHROIDLEVOTHYROXINE SODIUM0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-007UNITHROIDLEVOTHYROXINE SODIUM0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-008UNITHROIDLEVOTHYROXINE SODIUM0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-009UNITHROIDLEVOTHYROXINE SODIUM0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-010UNITHROIDLEVOTHYROXINE SODIUM0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21
N021210-011UNITHROIDLEVOTHYROXINE SODIUM0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD, RS2000-08-21
N021210-012UNITHROIDLEVOTHYROXINE SODIUM0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2008-02-08

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 36 matching rows.

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06N021210-001UNITHROID0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21a50c72e98297…
2026-08-01 22:54:322026-06N021210-002UNITHROID0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21a50c72e98297…
2026-08-01 22:54:322026-06N021210-003UNITHROID0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21a50c72e98297…
2026-08-01 22:54:322026-06N021210-004UNITHROID0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21a50c72e98297…
2026-08-01 22:54:322026-06N021210-005UNITHROID0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21a50c72e98297…
2026-08-01 22:54:322026-06N021210-006UNITHROID0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21a50c72e98297…
2026-08-01 22:54:322026-06N021210-007UNITHROID0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21a50c72e98297…
2026-08-01 22:54:322026-06N021210-008UNITHROID0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21a50c72e98297…
2026-08-01 22:54:322026-06N021210-009UNITHROID0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21a50c72e98297…
2026-08-01 22:54:322026-06N021210-010UNITHROID0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2000-08-21a50c72e98297…
2026-08-01 22:54:322026-06N021210-011UNITHROID0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD, RS2000-08-21a50c72e98297…
2026-08-01 22:54:322026-06N021210-012UNITHROID0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine SodiumTABLET / ORALAB1,AB2,AB3RLD2008-02-08a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06N021210-001AB11a50c72e98297…
2026-08-01 22:54:322026-06N021210-001AB22a50c72e98297…
2026-08-01 22:54:322026-06N021210-001AB33a50c72e98297…
2026-08-01 22:54:322026-06N021210-002AB11a50c72e98297…
2026-08-01 22:54:322026-06N021210-002AB22a50c72e98297…
2026-08-01 22:54:322026-06N021210-002AB33a50c72e98297…
2026-08-01 22:54:322026-06N021210-003AB11a50c72e98297…
2026-08-01 22:54:322026-06N021210-003AB22a50c72e98297…
2026-08-01 22:54:322026-06N021210-003AB33a50c72e98297…
2026-08-01 22:54:322026-06N021210-004AB11a50c72e98297…
2026-08-01 22:54:322026-06N021210-004AB22a50c72e98297…
2026-08-01 22:54:322026-06N021210-004AB33a50c72e98297…
2026-08-01 22:54:322026-06N021210-005AB11a50c72e98297…
2026-08-01 22:54:322026-06N021210-005AB22a50c72e98297…
2026-08-01 22:54:322026-06N021210-005AB33a50c72e98297…
2026-08-01 22:54:322026-06N021210-006AB11a50c72e98297…
2026-08-01 22:54:322026-06N021210-006AB22a50c72e98297…
2026-08-01 22:54:322026-06N021210-006AB33a50c72e98297…
2026-08-01 22:54:322026-06N021210-007AB11a50c72e98297…
2026-08-01 22:54:322026-06N021210-007AB22a50c72e98297…
2026-08-01 22:54:322026-06N021210-007AB33a50c72e98297…
2026-08-01 22:54:322026-06N021210-008AB11a50c72e98297…
2026-08-01 22:54:322026-06N021210-008AB22a50c72e98297…
2026-08-01 22:54:322026-06N021210-008AB33a50c72e98297…
2026-08-01 22:54:322026-06N021210-009AB11a50c72e98297…
2026-08-01 22:54:322026-06N021210-009AB22a50c72e98297…
2026-08-01 22:54:322026-06N021210-009AB33a50c72e98297…
2026-08-01 22:54:322026-06N021210-010AB11a50c72e98297…
2026-08-01 22:54:322026-06N021210-010AB22a50c72e98297…
2026-08-01 22:54:322026-06N021210-010AB33a50c72e98297…
2026-08-01 22:54:322026-06N021210-011AB11a50c72e98297…
2026-08-01 22:54:322026-06N021210-011AB22a50c72e98297…
2026-08-01 22:54:322026-06N021210-011AB33a50c72e98297…
2026-08-01 22:54:322026-06N021210-012AB11a50c72e98297…
2026-08-01 22:54:322026-06N021210-012AB22a50c72e98297…
2026-08-01 22:54:322026-06N021210-012AB33a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Levothyroxine SodiumLEVOTHYROXINE SODIUMNCS HealthCare of KY, LLC dba Vangard Labsabe173cc-1579-43a5-b12d-a31958d0a5392026-06-04Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021210
application number: NDA021210
Levothyroxine SodiumLEVOTHYROXINE SODIUMNorthwind Health Company, LLCc968836a-f94c-4d13-e053-2995a90a8df52026-01-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021210
application number: NDA021210
Levothyroxine SodiumLEVOTHYROXINE SODIUMAmneal Pharmaceuticals NY LLCfca88c97-5cd4-4834-ba87-deb5bd6377882024-12-06Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021210
application number: NDA021210
Levothyroxine SodiumLEVOTHYROXINE SODIUMProficient Rx LP2f0657d5-3e5c-4249-bfaa-7f5ef15286722021-01-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021210
application number: NDA021210
Levothyroxine SodiumLEVOTHYROXINE SODIUMProficient Rx LP97e28b00-9913-463f-9de2-08c828edbe672020-03-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021210
application number: NDA021210
Levothyroxine SodiumLEVOTHYROXINE SODIUMProficient Rx LP05ab038e-45fa-488e-a05e-12a2dd3564c12020-01-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021210
application number: NDA021210
Levothyroxine SodiumLEVOTHYROXINE SODIUMProficient Rx LPb81720f9-2836-4c1d-8691-0f6acef133162020-01-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021210
application number: NDA021210
Levothyroxine SodiumLEVOTHYROXINE SODIUMProficient Rx LP434075d5-a82b-4f17-85e6-4c1922663dbc2019-10-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021210
application number: NDA021210
Levothyroxine SodiumLEVOTHYROXINE SODIUMProficient Rx LP18c7c63a-642e-47fe-a8ee-12aaf652b2aa2019-10-01Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021210
application number: NDA021210
UnithroidLEVOTHYROXINE SODIUMAmneal Pharmaceuticals LLC07562e72-7eaa-4ce6-94f0-e08814787e502019-06-19Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 021210
application number: NDA021210

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
97c252d3-9bb8-4530-bb44-9824dc7cf556Product name620250729
6c43b71c-35e6-4db3-ba24-c6ef42ff7003Product name320240207
890fd4bf-1a80-42b7-be1b-2d0259d5f0c8Product name520240207
c8ad26bf-af73-460b-b74e-1eff16cc4f9fProduct name520240207
01383843-4069-43cf-aa76-dc17a6f9f8c4Product name220230123
978cca7d-a938-4791-8322-da48d90a63efProduct name120230113
65f86ba3-8816-4e12-899b-18290c8de551Product name220210614
f16ab90f-08c2-40be-a543-66d9827cd1f3Product name120210601
6a33ec05-2ae2-45e5-ab82-2d94b3303923Product name120190709
93355a10-1c44-4c92-a11d-7d995e0200d9Product name120190219

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
50436-5503-12020-01-31C16284748780-19d75b9d0-577c-f424-e053-dadaa90a57ceLevothyroxine Sodium Tablets, USP
50436-5503-22020-01-31C16284748780-19d75b9d0-577c-f424-e053-dadaa90a57ceLevothyroxine Sodium Tablets, USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50436-5503-1Levothyroxine Sodium30 in 1 BOTTLETABLET302
50436-5503-2Levothyroxine Sodium90 in 1 BOTTLETABLET902

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
LEVOTHYROXINE SODIUM ANHYDROUSACTIVE INGREDIENT054I36CPMNLEVOTHYROXINE SODIUM TABLET [UNIT DOSE SERVICES]2
LEVOTHYROXINEACTIVE MOIETYQ51BO43MG4LEVOTHYROXINE SODIUM TABLET [UNIT DOSE SERVICES]2
ACACIAINACTIVE INGREDIENT5C5403N26OLEVOTHYROXINE SODIUM TABLET [UNIT DOSE SERVICES]2
ALUMINUM OXIDEINACTIVE INGREDIENTLMI26O6933LEVOTHYROXINE SODIUM TABLET [UNIT DOSE SERVICES]2
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61ULEVOTHYROXINE SODIUM TABLET [UNIT DOSE SERVICES]2
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A8LEVOTHYROXINE SODIUM TABLET [UNIT DOSE SERVICES]2
LACTOSEINACTIVE INGREDIENTJ2B2A4N98GLEVOTHYROXINE SODIUM TABLET [UNIT DOSE SERVICES]2
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30LEVOTHYROXINE SODIUM TABLET [UNIT DOSE SERVICES]2
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4LEVOTHYROXINE SODIUM TABLET [UNIT DOSE SERVICES]2
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2LEVOTHYROXINE SODIUM TABLET [UNIT DOSE SERVICES]2
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJLEVOTHYROXINE SODIUM TABLET [UNIT DOSE SERVICES]2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50436-5503LEVOTHYROXINE SODIUM TABLET [UNIT DOSE SERVICES]2Legacy NDC, 2 package rows20131007_3f7bf9a8-fcfa-47fc-826d-c36174abbca0.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
966220levothyroxine sodium 25 MCG Oral TabletPSN3f7bf9a8-fcfa-47fc-826d-c36174abbca02
966220levothyroxine sodium 0.025 MG Oral TabletSCD3f7bf9a8-fcfa-47fc-826d-c36174abbca02
966220levothyroxine sodium 25 MCG Oral TabletSY3f7bf9a8-fcfa-47fc-826d-c36174abbca02

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
50436-5503-15043655030130 in 1 BOTTLEHistorical
50436-5503-25043655030290 in 1 BOTTLEHistorical